Precision tool
to study single cell gene expression
SCellex is a biotech company developing advanced tools for the single-cell omics field, a key driver of innovation in life sciences. There is a growing need for high-resolution, scalable solutions to accelerate diagnostics, drug discovery, and personalized therapies. A major application is cancer research, where understanding cellular heterogeneity and drug responses at single-cell and spatial resolution is crucial for effective treatment development.
SCellex’s spatial technology is based on patent-pending visual barcoding of single-cell-sized picowells in an array, utilizing random combinations of coloured feature barcode beads. Chips loaded with beads are imaged and AI-analyzed, making them ready for RNA capture directly from tissue sections or single-cell suspensions in a high-throughput manner. This versatile barcoding technology also enables high-throughput multi-omics and functional assays.
Visual barcoding beads and array
SCellex visual barcoding beads and array
- Visual colour bead features enable the generation of over million unique random combinations
- High throughput picowell arrays with 200 000 wells/cm2 with 20um resolution
- Pre-loaded and imaged arrays, ready-to-use
- Patent pending technology
- For research use only

SCellex News
Visit SCellex booth at AACR Chicago April 27-30, 2025
SCellex is attending AACR (American Association for Cancer Research) meeting in Chicago April 27-30, 2025. If you are attending the meeting, please visit our booth (location 2363) to meet us!
SCellex at Single Cell Omics symposium in Helsinki March 13, 2025
It was our pleasure to be one of the sponsors of the meeting. Great agenda and presentations, good discussions at SCellex booth!SCellex attends Slush November 20-21, 2024
Joining world’s biggest startup meeting. Outside cold, inside energy and entrepreneurs.